Anavex Life Sciences Corp (AVXL)

[WolfofMia]

History has taught us that being first to market is not always best.

Being second to market with a drug that doesnt have the side effects of the first, of diarrhea in a disease that is so physically debilitating, is.

What they did set for us is as you mentioned is a very high price tag.

Imagine we come in and price our drug at 300K a year (to match Steady`s estimates), with less side effect, and hopefully more efficacy, worst case same efficacy.

In worst case scenario, that there is no combo treatment which is suspect there will be, who would insurance rather cover?

Or rather what would be cheaper for the special programs in place which cover these treatments?

Asking for a friend in Care Bear Land, aka Denmark.